OLAWALE M OSUNSANYA

Allopathic & Osteopathic Physicians|Internal Medicine|Nephrology DOTHAN, AL NPI 1013998491

General Payments — all program years on this page

$1,043.34

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 41
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $431.15 across 21 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $383.1216
Education $48.035

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2018 $16.831
2019 $384.377
2020 $37.152
2021 $124.276
2023 $49.574
2024 $431.1521

Records — PY2024 (21)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1086123862 Bayer Healthcare Pharmaceuticals Inc. $30.35 04/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1086197452 Bayer Healthcare Pharmaceuticals Inc. $18.57 05/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104729977 AstraZeneca Pharmaceuticals LP $21.26 02/15/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105416727 AstraZeneca Pharmaceuticals LP $18.78 06/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117839387 Boehringer Ingelheim Pharmaceuticals, Inc. $21.99 03/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117839389 Boehringer Ingelheim Pharmaceuticals, Inc. $23.93 06/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117839391 Boehringer Ingelheim Pharmaceuticals, Inc. $25.52 11/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117839393 Boehringer Ingelheim Pharmaceuticals, Inc. $26.77 07/31/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1124058644 Vifor Pharma, Inc. $21.99 09/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1141517171 CALLIDITAS THERAPEUTICS US INC. $25.25 06/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1141523065 CALLIDITAS THERAPEUTICS US INC. $20.64 09/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1145825333 AKEBIA THERAPEUTICS INC $26.93 05/15/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1145828616 AKEBIA THERAPEUTICS INC $24.70 08/28/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1145832983 AKEBIA THERAPEUTICS INC $24.61 08/28/2024 Education Undisputed 01/23/2026 View at CMS
1149909917 Travere Therapeutics, Inc. $0.37 09/20/2024 Education Undisputed 01/23/2026 View at CMS
1149909921 Travere Therapeutics, Inc. $3.08 01/25/2024 Education Undisputed 01/23/2026 View at CMS
1149909925 Travere Therapeutics, Inc. $3.08 02/29/2024 Education Undisputed 01/23/2026 View at CMS
1149909929 Travere Therapeutics, Inc. $16.89 02/29/2024 Education Undisputed 01/23/2026 View at CMS
1150689001 Aurinia Pharma U.S., Inc. $25.20 10/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1154207120 Fresenius USA Marketing, Inc. $24.10 04/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1154207122 Fresenius USA Marketing, Inc. $27.14 03/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.